Gastroenterology and Hepatology - Issue 4/2023

Editorial

271

Clinical and experimental gastroenterology

T. Hucl

Clinical and Experimental Gastroenterology: Original Article

280

Hepatogenous diabetes in liver transplant candidates: prevalence, risk factors and posttransplant outcome – prospective study

Irena Míková, D. Erhartová Kyselová, K. Dvořáková, M. Dezortová, M. Hájek, V. Lánská, Julius Špičák, Pavel Trunečka

289

Biofeedback assisted deep breathing training in refractory disorders of gut-brain interaction – our first experience, impressions and suggestions for further clinical practice

Peter Lipták, I. Tonhajzerová, Martin Ďuriček, Z. Višňovcová, N. Ferencová, Diana Vážanová, P. Bánovčin Jr.

295

Robotic pancreatic surgery in a high-volume pancreatic cancer surgery center – first experience

M. Loveček, P. Skalický, Dušan Klos

307

Impact of the COVID-19 pandemic on acute pancreatitis in the Czech Republic – pilot data PANACOTA study (PANcreatitis Acuta in COVid Time Analysis)

M. Harazím, R. Kroupa, Jiří Jarkovský, O. Šanca, T. Andrašina, V. Procházka, M. Šenkyřík

326

EUS guided drainage of gallbladder: own cohort of 66 patients for the period 2016–2022 from the Hospital Jablonec nad Nisou

J. Pintová, R. Procházka, M. Man, V. Nosek

302

Chest pain as an atypical symptom of acute cholecystitis

V. Kovaříková, J. Tůma, J. Maceček

Clinical and Experimental Gastroenterology: Review Article

315

Changing epidemiology of Clostridioides difficile infection – increasing number of community-acquired forms and infections in children

M. Sučík, R. Rosoľanka, K. Šimeková, P. Bánovčin Jr., M. Schnierer

322

Why should we and should we not use ChatGPT in gastroenterology?

Jan Král, K. Waloszková, J. Selucká, E. Machytka, Julius Špičák, M. Bužga

336

Switch from biosimilar infliximab CT-P13 to biosimilar infliximab SB-2 in the long-term maintenance therapy in IBD patients – prospective observational study

M. Lukáš, V. Hrubá, J. Reissigová, Karin Černá, N. Machková, D. Ďuricová, M. Kolář, K. Vlková, L. Čermáková, M. Lukáš Jr

342

Dosage forms of oral mesalazine and their clinical use

M. Lapka

347

Subkutánní infliximab – poznatky z praxe a další možnosti využití u pacientů s IBD

Commentary

350

The selection from international journals

354

Správná odpověď na předchozí kvíz

357

12th Club Symposium on Portal Hypertension April, 14th–15th 2023, Banská Štiavnica

360

44. české a slovenské endoskopické dny a Olomouc Live Endoscopy 2023

B. Pipek

362

Kreditovaný autodidaktický test: Klinická a experimentální gastroenterologie

Gastroenterology and Hepatology

2023 Issue 4